Skip to content
Trial Eligibility
Menu

Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts

NCT05625659

This study is recruiting at 11 US sites in 10 states, according to its ClinicalTrials.gov record last updated .

Summary

The over-arching goal of the Contrast-Enhanced Spectral Mammography Imaging Screening Trial (CMIST) is to determine if dual-energy contrast-enhanced spectral mammography (CESM) can detect more cancers with fewer false positives than digital breast tomosynthesis (DBT) in women with dense breasts. Aim 1: To evaluate the performance of CESM compared to DBT at baseline for breast-cancer screening in women with dense breasts. Aim 2: To evaluate the performance of CESM compared to DBT at the 1-year follow up for breast-cancer screening in women with dense breasts.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Breast Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
45 to 74 years
Sex
Female
Healthy volunteers
Accepted
Sponsor
American College of Radiology
Last updated on ClinicalTrials.gov
July 31, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Alabama · 1

  • University of Alabama, Birmingham · Birmingham, AL

Florida · 1

  • Boca Raton Regional Hospital - Christine E. Lynn Women's Health and Wellness Institute · Boca Raton, FL

Massachusetts · 2

  • Massachusetts General Hospital · Boston, MA
  • Boston Breast Diagnostic Center · Wellesley Hills, MA

Michigan · 1

  • Henry Ford Health · Detroit, MI

New Jersey · 1

  • Thomas Jefferson University · Sewell, NJ

New York · 1

  • Memorial Sloan Kettering Cancer Center · New York, NY

North Carolina · 1

  • Carolina Breast Imaging Specialists · Greenville, NC

Pennsylvania · 1

  • Thomas Jefferson University Hospital · Philadelphia, PA

Texas · 1

  • The University of Texas MD Anderson Cancer Center · Houston, TX

Virginia · 1

  • University of Virginia · Charlottesville, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.